Jae Hoon Chung. Endocr J 2020
Times Cited: 5
Times Cited: 5
Times Cited
Times Co-cited
Similarity
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
80
The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.
Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim,[...]. Cancer 2012
Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim,[...]. Cancer 2012
60
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Huy Gia Vuong, Ahmed Ma Altibi, Uyen Np Duong, Hanh Tt Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell,[...]. Tumour Biol 2017
Huy Gia Vuong, Ahmed Ma Altibi, Uyen Np Duong, Hanh Tt Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell,[...]. Tumour Biol 2017
40
Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
Qing Zhang, Shao-zheng Liu, Qing Zhang, Yan-xing Guan, Qing-jie Chen, Qin-yao Zhu. Cell Physiol Biochem 2016
Qing Zhang, Shao-zheng Liu, Qing Zhang, Yan-xing Guan, Qing-jie Chen, Qin-yao Zhu. Cell Physiol Biochem 2016
40
BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.
Ralph P Tufano, Gilberto V Teixeira, Justin Bishop, Kathryn A Carson, Mingzhao Xing. Medicine (Baltimore) 2012
Ralph P Tufano, Gilberto V Teixeira, Justin Bishop, Kathryn A Carson, Mingzhao Xing. Medicine (Baltimore) 2012
40
BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis.
Yufei Chen, Peter M Sadow, Hyunsuk Suh, Kyu Eun Lee, June Young Choi, Yong Joon Suh, Tracy S Wang, Carrie C Lubitz. Thyroid 2016
Yufei Chen, Peter M Sadow, Hyunsuk Suh, Kyu Eun Lee, June Young Choi, Yong Joon Suh, Tracy S Wang, Carrie C Lubitz. Thyroid 2016
40
Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.
Chunping Liu, Tianwen Chen, Zeming Liu. World J Surg Oncol 2016
Chunping Liu, Tianwen Chen, Zeming Liu. World J Surg Oncol 2016
40
Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
40
Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Meiling Huang, Changjiao Yan, Jingjing Xiao, Ting Wang, Rui Ling. Diagn Pathol 2019
Meiling Huang, Changjiao Yan, Jingjing Xiao, Ting Wang, Rui Ling. Diagn Pathol 2019
40
40
Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer.
Mingzhao Xing. BMC Med 2016
Mingzhao Xing. BMC Med 2016
40
Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.
Haixia Guan, Meiju Ji, Rong Bao, Hongyu Yu, Yangang Wang, Peng Hou, Yong Zhang, Zhongyan Shan, Weiping Teng, Mingzhao Xing. J Clin Endocrinol Metab 2009
Haixia Guan, Meiju Ji, Rong Bao, Hongyu Yu, Yangang Wang, Peng Hou, Yong Zhang, Zhongyan Shan, Weiping Teng, Mingzhao Xing. J Clin Endocrinol Metab 2009
20
20
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.
E L Mazzaferri, R T Kloos. J Clin Endocrinol Metab 2001
E L Mazzaferri, R T Kloos. J Clin Endocrinol Metab 2001
20
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
20
A different prognostic value of BRAFV600E mutation positivity in various age groups of patients with papillary thyroid cancer.
E Takacsova, R Kralik, I Waczulikova, K Zavodna, J Kausitz. Neoplasma 2017
E Takacsova, R Kralik, I Waczulikova, K Zavodna, J Kausitz. Neoplasma 2017
20
Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma.
Guoping He, Baojian Zhao, Xu Zhang, Rixiang Gong. Oncol Lett 2014
Guoping He, Baojian Zhao, Xu Zhang, Rixiang Gong. Oncol Lett 2014
20
BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence.
Samuel Enumah, Abbey Fingeret, Sareh Parangi, Dora Dias-Santagata, Peter M Sadow, Carrie C Lubitz. World J Surg 2020
Samuel Enumah, Abbey Fingeret, Sareh Parangi, Dora Dias-Santagata, Peter M Sadow, Carrie C Lubitz. World J Surg 2020
20
BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.
S Fraser, C Go, A Aniss, S Sidhu, L Delbridge, D Learoyd, R Clifton-Bligh, L Tacon, V Tsang, B Robinson,[...]. World J Surg 2016
S Fraser, C Go, A Aniss, S Sidhu, L Delbridge, D Learoyd, R Clifton-Bligh, L Tacon, V Tsang, B Robinson,[...]. World J Surg 2016
20
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
20
Association of MicroRNA Expression and BRAFV600E Mutation with Recurrence of Thyroid Cancer.
Daina Pamedytyte, Vaida Simanaviciene, Dalia Dauksiene, Enrika Leipute, Aurelija Zvirbliene, Valdas Sarauskas, Albertas Dauksa, Rasa Verkauskiene, Birute Zilaitiene. Biomolecules 2020
Daina Pamedytyte, Vaida Simanaviciene, Dalia Dauksiene, Enrika Leipute, Aurelija Zvirbliene, Valdas Sarauskas, Albertas Dauksa, Rasa Verkauskiene, Birute Zilaitiene. Biomolecules 2020
20
Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases.
Xiao-Min Yu, Yin Wan, Rebecca S Sippel, Herbert Chen. Ann Surg 2011
Xiao-Min Yu, Yin Wan, Rebecca S Sippel, Herbert Chen. Ann Surg 2011
20
20
Publication bias in clinical research.
P J Easterbrook, J A Berlin, R Gopalan, D R Matthews. Lancet 1991
P J Easterbrook, J A Berlin, R Gopalan, D R Matthews. Lancet 1991
20
Practical methods for incorporating summary time-to-event data into meta-analysis.
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah Burdett, Matthew R Sydes. Trials 2007
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah Burdett, Matthew R Sydes. Trials 2007
20
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Steven I Sherman, R Michael Tuttle. Thyroid 2006
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Steven I Sherman, R Michael Tuttle. Thyroid 2006
20
Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes.
Iwao Sugitani, Kazuhisa Toda, Keiko Yamada, Noriko Yamamoto, Motoko Ikenaga, Yoshihide Fujimoto. World J Surg 2010
Iwao Sugitani, Kazuhisa Toda, Keiko Yamada, Noriko Yamamoto, Motoko Ikenaga, Yoshihide Fujimoto. World J Surg 2010
20
Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Metastatic Breast Cancer: A Meta-Analysis.
Xin Li, Hyungju Kwon. J Clin Med 2019
Xin Li, Hyungju Kwon. J Clin Med 2019
20
Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, Jung Hyun Yang. Thyroid 2016
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, Jung Hyun Yang. Thyroid 2016
20
Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells.
Jong Bin Kim, Eun Yeol Yang, Joohyun Woo, Hyungju Kwon, Woosung Lim, Byung-In Moon. In Vivo 2020
Jong Bin Kim, Eun Yeol Yang, Joohyun Woo, Hyungju Kwon, Woosung Lim, Byung-In Moon. In Vivo 2020
20
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.
Daniele Barbaro, Roberto Mario Incensati, Gabriele Materazzi, Giuseppe Boni, Mariano Grosso, Erica Panicucci, Paola Lapi, Cristina Pasquini, Paolo Miccoli. Endocrine 2014
Daniele Barbaro, Roberto Mario Incensati, Gabriele Materazzi, Giuseppe Boni, Mariano Grosso, Erica Panicucci, Paola Lapi, Cristina Pasquini, Paolo Miccoli. Endocrine 2014
20
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients.
Yasuhiro Ito, Hiroshi Yoshida, Rie Maruo, Shinji Morita, Toru Takano, Mitsuyoshi Hirokawa, Tomonori Yabuta, Mitsuhiro Fukushima, Hiroyuki Inoue, Chisato Tomoda,[...]. Endocr J 2009
Yasuhiro Ito, Hiroshi Yoshida, Rie Maruo, Shinji Morita, Toru Takano, Mitsuyoshi Hirokawa, Tomonori Yabuta, Mitsuhiro Fukushima, Hiroyuki Inoue, Chisato Tomoda,[...]. Endocr J 2009
20
Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience.
Christopher Gouveia, Nhu Thuy Can, Alan Bostrom, James P Grenert, Annemieke van Zante, Lisa A Orloff. JAMA Otolaryngol Head Neck Surg 2013
Christopher Gouveia, Nhu Thuy Can, Alan Bostrom, James P Grenert, Annemieke van Zante, Lisa A Orloff. JAMA Otolaryngol Head Neck Surg 2013
20
Prognostic implications of the BRAF-V600E mutation in papillary thyroid carcinoma based on a new cut-off age stratification.
Xiaoxiong Gan, Fei Shen, Xingyan Deng, Jianhua Feng, Jiabao Lu, Wensong Cai, Lina Peng, Weipeng Zheng, Weijia Wang, Peidan Huang,[...]. Oncol Lett 2020
Xiaoxiong Gan, Fei Shen, Xingyan Deng, Jianhua Feng, Jiabao Lu, Wensong Cai, Lina Peng, Weipeng Zheng, Weijia Wang, Peidan Huang,[...]. Oncol Lett 2020
20
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti, Susi Barollo, Natalie Prinzi, Antonio Catania, Angela Nesca, Lucio Gnessi, Maria R Pelizzo, Caterina Mian,[...]. Clin Endocrinol (Oxf) 2012
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti, Susi Barollo, Natalie Prinzi, Antonio Catania, Angela Nesca, Lucio Gnessi, Maria R Pelizzo, Caterina Mian,[...]. Clin Endocrinol (Oxf) 2012
20
Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis.
Zhen Wang, Jun-Qiang Chen, Jin-Lu Liu, Xin-Gan Qin. Eur J Clin Invest 2016
Zhen Wang, Jun-Qiang Chen, Jin-Lu Liu, Xin-Gan Qin. Eur J Clin Invest 2016
20
Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma.
Chan-Kwon Jung, So-Young Im, Yeo-Ju Kang, Hyoungnam Lee, Eun-Sun Jung, Chang-Suk Kang, Ja-Seong Bae, Yeong-Jin Choi. Thyroid 2012
Chan-Kwon Jung, So-Young Im, Yeo-Ju Kang, Hyoungnam Lee, Eun-Sun Jung, Chang-Suk Kang, Ja-Seong Bae, Yeong-Jin Choi. Thyroid 2012
20
Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
20
BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma.
Lauren E Henke, John D Pfeifer, Changquing Ma, Stephanie M Perkins, Todd DeWees, Samir El-Mofty, Jeffrey F Moley, Brian Nussenbaum, Bruce H Haughey, Thomas J Baranski,[...]. Cancer Med 2015
Lauren E Henke, John D Pfeifer, Changquing Ma, Stephanie M Perkins, Todd DeWees, Samir El-Mofty, Jeffrey F Moley, Brian Nussenbaum, Bruce H Haughey, Thomas J Baranski,[...]. Cancer Med 2015
20
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.
Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo, Barbara Jarzab, Agnieszka Czarniecka,[...]. J Clin Oncol 2018
Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo, Barbara Jarzab, Agnieszka Czarniecka,[...]. J Clin Oncol 2018
20
An observational trial for papillary thyroid microcarcinoma in Japanese patients.
Yasuhiro Ito, Akira Miyauchi, Hiroyuki Inoue, Mitsuhiro Fukushima, Minoru Kihara, Takuya Higashiyama, Chisato Tomoda, Yuuki Takamura, Kaoru Kobayashi, Akihiro Miya. World J Surg 2010
Yasuhiro Ito, Akira Miyauchi, Hiroyuki Inoue, Mitsuhiro Fukushima, Minoru Kihara, Takuya Higashiyama, Chisato Tomoda, Yuuki Takamura, Kaoru Kobayashi, Akihiro Miya. World J Surg 2010
20
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017.
Seri Hong, Young-Joo Won, Young Ran Park, Kyu-Won Jung, Hyun-Joo Kong, Eun Sook Lee. Cancer Res Treat 2020
Seri Hong, Young-Joo Won, Young Ran Park, Kyu-Won Jung, Hyun-Joo Kong, Eun Sook Lee. Cancer Res Treat 2020
20
Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.
Bo Youn Cho, Hoon Sung Choi, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, Kyung Won Kim, Ka Hee Yi, June-Key Chung, Yeo-Kyu Youn,[...]. Thyroid 2013
Bo Youn Cho, Hoon Sung Choi, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, Kyung Won Kim, Ka Hee Yi, June-Key Chung, Yeo-Kyu Youn,[...]. Thyroid 2013
20
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.
I D Hay, E J Bergstralh, J R Goellner, J R Ebersold, C S Grant. Surgery 1993
I D Hay, E J Bergstralh, J R Goellner, J R Ebersold, C S Grant. Surgery 1993
20
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
Shinje Moon, Young Shin Song, Ye An Kim, Jung Ah Lim, Sun Wook Cho, Jae Hoon Moon, Seokyung Hahn, Do Joon Park, Young Joo Park. Thyroid 2017
Shinje Moon, Young Shin Song, Ye An Kim, Jung Ah Lim, Sun Wook Cho, Jae Hoon Moon, Seokyung Hahn, Do Joon Park, Young Joo Park. Thyroid 2017
20
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Bela Bendlová, Linwah Yip, Caterina Mian,[...]. J Clin Oncol 2015
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Bela Bendlová, Linwah Yip, Caterina Mian,[...]. J Clin Oncol 2015
20
A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer.
Alexander J Lin, Pamela Samson, Todd DeWees, Lauren Henke, Thomas Baranski, Julie Schwarz, John Pfeifer, Perry Grigsby, Stephanie Markovina. Cancer Med 2019
Alexander J Lin, Pamela Samson, Todd DeWees, Lauren Henke, Thomas Baranski, Julie Schwarz, John Pfeifer, Perry Grigsby, Stephanie Markovina. Cancer Med 2019
20
Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia.
Boban Stanojevic, Radan Dzodic, Vladimir Saenko, Zorka Milovanovic, Gordana Pupic, Ognjen Zivkovic, Ivan Markovic, Igor Djurisic, Marko Buta, Bogomir Dimitrijevic,[...]. Endocr J 2011
Boban Stanojevic, Radan Dzodic, Vladimir Saenko, Zorka Milovanovic, Gordana Pupic, Ognjen Zivkovic, Ivan Markovic, Igor Djurisic, Marko Buta, Bogomir Dimitrijevic,[...]. Endocr J 2011
20
Progress in molecular-based management of differentiated thyroid cancer.
Mingzhao Xing, Bryan R Haugen, Martin Schlumberger. Lancet 2013
Mingzhao Xing, Bryan R Haugen, Martin Schlumberger. Lancet 2013
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.